Myrtecaine

Myrtecaine
Clinical data
Trade names	Algesal, Algésal Suractivé
Other names	Nopoxamine
ATC code	none;
Identifiers
	IUPAC name 2-[2-(6,6-Dimethyl-2-bicyclo[3.1.1]hept-2-enyl)ethoxy]-N,N-diethylethanamine;
CAS Number	7712-50-7;
PubChem CID	71851;
ChemSpider	64868;
UNII	9902116282;
ChEBI	CHEBI:135096;
CompTox Dashboard (EPA)	DTXSID901016796 ;
ECHA InfoCard	100.028.851
Chemical and physical data
Formula	C17H31NO
Molar mass	265.441 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)CCOCCC1=CCC2CC1C2(C)C;
	InChI InChI=1S/C17H31NO/c1-5-18(6-2)10-12-19-11-9-14-7-8-15-13-16(14)17(15,3)4/h7,15-16H,5-6,8-13H2,1-4H3; Key:BZRYYBWNOUALTQ-UHFFFAOYSA-N;

Myrtecaine (Nopoxamine), sold as a combination product with diethylamine salicylate under the trade name Algesal and Algésal Suractivé among others, is a local anaesthetic in the form of a topical cream,^[2] or with laurilsulfate in rubefacient preparations.^[3] It is used to treat muscle strains, tendinitis or ligament sprains and joint pain.^[2]^[3]^[4] It is a surface anaesthetic, adds to the analgesic and anti-inflammatory actions of diethylamine salicylate by facilitating its penetration.^[5] Also myrtecaine has a muscle relaxant effect.^[2]

References

^ "Myrtecaine". PubChem. National Center for Biotechnology Information, U.S. National Library of Medicine. Retrieved 2020-08-22.
^ ^a ^b ^c "Algesal-Creme" (in German). Bundesamt für Sicherheit im Gesundheitswesen. December 2017.
^ ^a ^b "Myrtecaine". Drugster.org.
^ Elks J, Ganellin CR (1990). "Myrtecaine M-00475". Dictionary of drugs: chemical data, structures, and bibliographies (1st ed.). Dordrecht: Springer. p. 844. ISBN 978-1-4757-2085-3.
^ "Algesal Cream - Patient Information Leaflet" (PDF). Chemipharm Pharmaceutical Industries, Inc.

This dermatologic drug article is a stub. You can help Wikipedia by expanding it.